Tags: Chronic Pain | oral | migraine | drug | headache | atogepant

Oral Migraine Drug Effective in Study

Oral Migraine Drug Effective in Study
(Copyright iStock)

Tuesday, 12 June 2018 08:17 AM

Allergan Plc said on Monday its oral migraine drug met the main goal across all doses in a study, with a statistically significant reduction in monthly headache days in patients with episodic migraine.

The treatment, atogepant, belongs to a class of migraine drugs also being developed by Eli Lilly and Alder Biopharmaceuticals that target a protein associated with pain signaling called calcitonin gene-related peptide (CGRP).

Last month, the U.S. Food and Drug Administration approved Amgen Inc's CGRP treatment Aimovig, which is self injected monthly and will have a list price of $6,900 a year, or $575 a month.

Questions have been raised about Amgen's strategy for Aimovig after the nation's largest manager of prescription benefits, Express Scripts, told Reuters it is pressing Amgen and rival makers of new migraine-preventing drugs to reconsider the usual strategy of high list prices and hefty rebates.

Allergan, which aims to bring the first oral CGRP to the market, has two such drugs in its pipeline.

Last month, the company reported positive results from a second late-stage trial for the 50 milligram dose of its other migraine drug ubrogepant.

© 2021 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
Health-News
Allergan Plc said on Monday its oral migraine drug met the main goal across all doses in a study, with a statistically significant reduction in monthly headache days in patients with episodic migraine. The treatment, atogepant, belongs to a class of migraine drugs also being...
oral, migraine, drug, headache, atogepant
184
2018-17-12
Tuesday, 12 June 2018 08:17 AM
Newsmax Media, Inc.
 
Newsmax TV Live

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved